Lemonade, Inc. Earnings Per Share Disclosure
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Numerator: | |||||||||||||||||
| Net loss attributable to common stockholders (in millions) | $ | (165.5) | $ | (202.2) | $ | (236.9) | |||||||||||
| Denominator: | |||||||||||||||||
Weighted average common shares outstanding — basic and diluted | 73,943,632 | 71,023,115 | 69,658,912 | ||||||||||||||
Net loss per share attributable to common stockholders — basic and diluted | $ | (2.24) | $ | (2.85) | $ | (3.40) | |||||||||||
| December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Options to purchase common stock | 7,253,851 | 9,376,193 | 9,595,257 | ||||||||||||||
| Unvested restricted stock | 3,196,072 | 4,278,383 | 3,568,735 | ||||||||||||||
Warrants for common stock (1) | 412,969 | 412,969 | 412,969 | ||||||||||||||
| 10,862,892 | 14,067,545 | 13,576,961 | |||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 25, 2026 | Showing above |
| 2024 | Feb 26, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Mar 3, 2023 | |
| 2021 | Mar 1, 2022 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.